je.st
news
Merck Sues Actavis Unit Over Patent for Generic NuvaRing
2013-12-25 00:26:03| Biotech - Topix.net
Merck & Co. sued Actavis Plc's Warner Chilcott unit seeking to block sales of a generic version of NuvaRing, a contraceptive with estimated annual sales of more than $664 million.
Tags: unit
patent
generic
merck
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||